SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VARANI, Katia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.958
EU - Europa 8.874
AS - Asia 6.121
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 19
OC - Oceania 16
AF - Africa 4
Totale 44.013
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.927
CN - Cina 3.351
UA - Ucraina 2.273
DE - Germania 1.952
TR - Turchia 1.755
IT - Italia 1.557
GB - Regno Unito 933
SE - Svezia 741
SG - Singapore 692
FI - Finlandia 518
PL - Polonia 316
RU - Federazione Russa 213
FR - Francia 130
HK - Hong Kong 108
VN - Vietnam 83
BE - Belgio 67
CZ - Repubblica Ceca 59
ID - Indonesia 44
NL - Olanda 39
CA - Canada 27
IN - India 21
IR - Iran 20
EU - Europa 18
ES - Italia 17
JP - Giappone 12
AU - Australia 11
AT - Austria 10
RO - Romania 10
CL - Cile 8
BR - Brasile 7
CH - Svizzera 6
HU - Ungheria 5
IE - Irlanda 5
IL - Israele 5
KR - Corea 5
NZ - Nuova Zelanda 5
MX - Messico 4
MY - Malesia 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
GR - Grecia 3
HR - Croazia 3
PK - Pakistan 3
TW - Taiwan 3
DZ - Algeria 2
IM - Isola di Man 2
IQ - Iraq 2
JO - Giordania 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MC - Monaco 1
ME - Montenegro 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 44.013
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.958
Fairfield 3.394
Jacksonville 2.602
Chandler 2.498
Houston 2.382
Ann Arbor 2.135
Ashburn 1.745
Wilmington 1.418
Seattle 1.328
Cambridge 1.109
Izmir 893
Nanjing 781
Beijing 662
Princeton 585
Boardman 469
Ferrara 443
Singapore 390
Warsaw 312
San Diego 301
Shanghai 299
Milan 295
Nanchang 250
Shenyang 232
Dearborn 179
Bremen 167
Changsha 148
Hebei 148
New York 146
Tianjin 143
Addison 140
Jiaxing 136
Hong Kong 105
San Mateo 99
Falls Church 90
Jinan 86
Norwalk 83
Zhengzhou 82
Dong Ket 81
Kunming 77
Mountain View 70
Los Angeles 68
Brussels 66
Auburn Hills 59
Orange 58
London 57
Düsseldorf 54
Ningbo 53
Redwood City 49
Philadelphia 47
Guangzhou 44
Jakarta 43
Washington 43
Des Moines 39
Brno 37
Tappahannock 37
Bologna 35
Taizhou 34
Augusta 32
Helsinki 32
Indiana 30
Verona 29
Chicago 28
Hangzhou 28
Munich 27
Rome 26
Lanzhou 25
Redmond 21
Haikou 17
Hefei 17
Leawood 17
Olomouc 17
Ardabil 16
Ferrara di Monte Baldo 16
Kilburn 16
Florence 13
Changchun 12
Bari 11
Chiswick 11
Padova 11
San Francisco 10
Aversa 9
Meppel 9
Otura 9
Amsterdam 8
Hounslow 8
Monmouth Junction 8
Taiyuan 8
Cagliari 7
Edinburgh 7
Fuzhou 7
Mcallen 7
New Bedfont 7
Tokyo 7
Clifton 6
Frankfurt am Main 6
Genoa 6
Montebelluna 6
Montréal 6
Toronto 6
Acton 5
Totale 31.888
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 315
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 224
A glance at adenosine receptors: Novel target for antitumor therapy 193
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 190
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 188
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 187
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 178
The A3 adenosine receptor: history and perspectives 161
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 159
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 158
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 153
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 153
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 151
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 151
Recettori e trasduzione del segnale 149
Pharmacology of Adenosine Receptors: The State of the Art 148
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 147
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 145
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 142
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 142
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 141
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 140
Pathological overproduction: the bad side of adenosine 140
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 138
Current status of A1 adenosine receptor allosteric enhancers 138
Adenosine receptors and human melanoma 137
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 133
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 133
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 133
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 133
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 132
Adenosine receptor targeting in health and disease 131
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 131
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 128
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 128
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 127
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 126
Comparison of Prazosin, Terazosin and Tamsulosin: Functional and Binding Studies in Isolated Prostatic and Vascular Human Tissues. 124
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 124
A Consensus Panel Review of Central Nervous System Effects of the Exposure to Low-Intensity Extremely Low-Frequency Magnetic Fields 124
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 124
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 123
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 122
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 121
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 121
null 121
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 121
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 120
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 120
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 120
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 120
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 120
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 120
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 119
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 118
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 118
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 118
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 118
Ala scan analogues of HOE 140. Synthesis and biological activities 117
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 117
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 117
Binding thermodynamics at A1 and A2A adenosine receptors 116
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 116
Adenosine signaling contributes to ethanol-induced fatty liver in mice 115
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 115
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 115
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 114
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 114
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 114
Biochemical characterization of A1 adenosine receptors: experimental evaluation of their binding and intrinsic activity parameters 114
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 114
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 114
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 114
Design, synthesis, and preliminary pharmacological evaluation of new quinoline derivatives as nicotinic ligands 113
null 113
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 113
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 113
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 113
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 113
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 113
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 113
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 113
null 113
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 112
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 112
null 112
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 112
Medicinal Chemistry of A3 Adenosine Receptor Modulators: Pharmacological Activities and Therapeutic Implications 112
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 112
New potent and selective human adenosine A3 receptor antagonists. 112
The A3 adenosine receptor: an enigmatic player in cell biology. 111
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 111
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 111
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 111
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 110
The role of adenosine receptors in rheumatoid arthritis. 110
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 110
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 110
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 109
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 109
Totale 12.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.867
Totale 179.584
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.757 1.602 257 238 1.201 502 1.027 757 906 636 1.021 463 147
2020/20216.868 600 670 242 788 344 711 276 826 165 951 888 407
2021/20225.145 126 552 340 225 245 210 232 269 193 432 731 1.590
2022/20235.734 592 432 176 795 954 821 269 458 700 46 296 195
2023/20242.851 289 377 142 83 316 343 136 209 57 72 77 750
2024/2025301 301 0 0 0 0 0 0 0 0 0 0 0
Totale 44.674